Axon Enterprise (NASDAQ:AXON) Price Target Increased to $310.00 by Analysts at Morgan Stanley

Axon Enterprise (NASDAQ:AXON) had its price objective increased by Morgan Stanley from $285.00 to $310.00 in a report released on Friday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock.

Several other research firms have also recently issued reports on AXON. JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an overweight rating in a research note on Thursday, April 11th. William Blair reissued an outperform rating on shares of Axon Enterprise in a report on Wednesday. Barclays boosted their price target on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an overweight rating in a report on Thursday, February 29th. Needham & Company LLC reissued a buy rating and issued a $400.00 price target on shares of Axon Enterprise in a report on Wednesday. Finally, TheStreet lowered shares of Axon Enterprise from a b rating to a c+ rating in a report on Tuesday, February 27th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $314.91.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $308.23 on Friday. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The company has a 50 day simple moving average of $303.45 and a two-hundred day simple moving average of $260.90. Axon Enterprise has a 12 month low of $175.37 and a 12 month high of $329.87. The stock has a market cap of $23.26 billion, a price-to-earnings ratio of 134.01 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm had revenue of $432.14 million during the quarter, compared to analysts’ expectations of $418.97 million. As a group, analysts predict that Axon Enterprise will post 2.44 earnings per share for the current year.

Institutional Investors Weigh In On Axon Enterprise

Large investors have recently modified their holdings of the business. ICA Group Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $26,000. Trivant Custom Portfolio Group LLC purchased a new stake in shares of Axon Enterprise in the first quarter valued at about $31,000. First PREMIER Bank purchased a new stake in shares of Axon Enterprise in the first quarter valued at about $33,000. BKM Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at about $32,000. Finally, Blue Bell Private Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the first quarter valued at about $41,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.